- $638.61m
- $616.77m
- $363.14m
- 36
- 49
- 52
- 42
2019 February 28th | 2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 February 28th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 94.8 | 133 | 170 | 310 | 363 |
Cost of Revenue | |||||
Gross Profit | 34.2 | 58.8 | 76.7 | 141 | 164 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 149 | 181 | 217 | 436 | 827 |
Operating Profit | -54 | -48.2 | -46.8 | -126 | -464 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -56.4 | -51.2 | -50.6 | -129 | -463 |
Provision for Income Taxes | |||||
Net Income After Taxes | -56.5 | -51.4 | -50.7 | -123 | -460 |
Net Income Before Extraordinary Items | |||||
Net Income | -56.5 | -51.4 | -50.7 | -123 | -460 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -56.5 | -51.4 | -50.7 | -123 | -460 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.2 | -1.09 | -1.72 | -1.79 | -3.64 |
Dividends per Share |